Fluorescence imaging in the second near-infrared window (NIR-II, 1000-1700 nm) is a highly promising and emerging technique for biomedical applications because of its deeper tissue penetration capability and higher signal-background ratio (SBR) compared to traditional imaging approaches using the shorter emission wavelength windows. [1] Numerous novel NIR-II fluorophores have been developed and evaluated in small animal models. [1] Importantly, a conventional NIR Fluorescence imaging in the second near-infrared window (NIR-II, 1000-1700 nm) holds great promise for deep tissue visualization. Development of novel clinical translatable NIR-II probes is crucial for realizing the medical applications of NIR-II fluorescence imaging. Herein, the glutathione-capped gold nanoclusters (AuNCs, specifically Au 25 (SG) 18) demonstrate highly efficient binding capability to hydroxyapatite in vitro for the first time. Further in vivo NIR-II fluorescence imaging of AuNCs indicate that they accumulate in bone tissues with high contrast and signal-background ratio. AuNCs are also mainly and quickly excreted from body through renal system, showing excellent ribs and thoracic vertebra imaging because of no background signal in liver and spleen. The deep tissue penetration capability and high resolution of AuNCs in NIR-II imaging render their great potential for fluorescence-guided surgery like spinal pedicle screw implantation. Overall, AuNCs are highly promising and clinical translatable NIR-II imaging probe for visualizing bone and bone related abnormalities.